LifeMD (NASDAQ:LFMDP) Shares Down 0.1% – Should You Sell?

Shares of LifeMD, Inc. (NASDAQ:LFMDPGet Free Report) were down 0.1% during mid-day trading on Monday . The stock traded as low as $22.55 and last traded at $22.57. Approximately 2,679 shares traded hands during mid-day trading, a decline of 2% from the average daily volume of 2,734 shares. The stock had previously closed at $22.60.

LifeMD Stock Performance

The firm’s 50-day simple moving average is $22.40 and its 200 day simple moving average is $22.24.

LifeMD Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, January 15th. Shareholders of record on Friday, January 3rd were given a dividend of $0.5547 per share. This represents a $2.22 annualized dividend and a dividend yield of 9.83%. The ex-dividend date of this dividend was Friday, January 3rd.

About LifeMD

(Get Free Report)

LifeMD, Inc operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies.

Further Reading

Receive News & Ratings for LifeMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeMD and related companies with MarketBeat.com's FREE daily email newsletter.